Local preview using the live theme CSS. Header and footer omitted. Yellow = placeholder to replace.
IRCE > Grants > SECURE-Nigeria > Laboratory

SECURE-Nigeria: Laboratory

← SECURE-Nigeria overview
On this page
Completed SECURE-Nigeria sub-project

Laboratory Optimisation

Fast, accurate laboratory confirmation turns a suspected outbreak into a response. SECURE-Nigeria strengthened both the laboratories and the way their results reach the national disease reporting system.

Nigeria’s 2017 Joint External Evaluation found that laboratory results travelled separately from disease reports, with long delays. SECURE-Nigeria set out to strengthen national and state laboratories to diagnose priority diseases using molecular tests, and to bring laboratory information into the surveillance system.

The project expanded polymerase chain reaction (PCR) testing, a molecular test that detects a pathogen’s genetic material, for 11 priority diseases in seven national and state laboratories. It set up tests at the National Reference Laboratory in Abuja that check one sample for several pathogens at once, created a back-up biorepository in Lagos, and redesigned how laboratory results are recorded and linked to cases in SORMAS.

11Priority diseases that can now be confirmed by PCR testing
7National and state laboratories strengthened
60,224Blood samples tested for antibodies to the virus that causes COVID‑19
1New back-up biorepository, at the Central Public Health Laboratory in Lagos

The challenge

Too few laboratories could run molecular tests, so suspected outbreaks took too long to confirm. When tests were done, the results often did not reach the surveillance system correctly: laboratory records in SORMAS lacked the case identification (EPID) number, were missing disease-specific details, and had inconsistent dates and incorrect state assignments.

Next: What we did →

What we did

Expanded PCR testing

Scaled up PCR testing for 11 priority diseases: [list diseases: confirm].

Multi-pathogen testing

Tests at the National Reference Laboratory check one sample for several pathogens at once, supporting surveillance of patients with sudden fever. Sentinel hospitals test for dengue and chikungunya on site.

Measured past COVID-19 infection

Using multiplex bead assay technology, which measures antibodies to several targets at once, the National Reference Laboratory tested 42,820 leftover HIV viral load samples from Nigeria’s six geopolitical zones, 15,252 dried blood spots from antenatal clinics in four states, and 2,152 samples from health workers in Rivers, Oyo and Plateau.

Back-up sample storage

Set up a working biorepository at the Central Public Health Laboratory in Yaba, Lagos, as a campus of the National Reference Laboratory, to store a back-up of the country’s biological samples.

Lassa fever testing in Ondo State

Equipped the laboratory at the Infectious Disease Hospital in Akure with a Class III biosafety cabinet (a sealed glove box for handling dangerous samples safely) and haematology and chemistry analysers, and trained laboratory scientists in quality management. Since March 2025 the hospital can confirm Lassa fever on site instead of sending samples to Owo. Ondo State accounted for 32% of Nigeria’s confirmed Lassa fever cases in 2023.

Quality assurance

Set up quality control and external quality assessment (proficiency testing) programmes so laboratories can show their results are accurate.

Wider respiratory testing

Expanded influenza testing to include other respiratory infections: whooping cough (pertussis) and diphtheria.

Genetic sequencing

Supported genetic sequencing of the virus that causes COVID-19.

Laboratory data in SORMAS

Laboratory records now link to the right case automatically by EPID number, capture every detail on the national paper forms, and are checked for logical dates and the correct state.

Next: Results →

Results

Quicker confirmation of outbreaks

Seven laboratories can confirm 11 priority diseases by PCR, so public health action can start sooner.

National evidence on COVID-19 infection

More than 60,000 samples tested for antibodies across different population groups and regions.

Safer sample storage

A second biorepository site protects the national collection of biological samples.

Laboratory indicators people can trust

Better linking of laboratory results to cases improves confidence in measures such as how long results take and what share of tests are positive.

Next: Sites →

Sites

  • Federal Capital Territory: National Reference Laboratory, NCDC, Gaduwa
  • Lagos: Central Public Health Laboratory, Yaba
  • Ondo: Infectious Disease Hospital, Akure
  • [State]: [Other supported laboratories: confirm]

Next: Lessons learned →

Lessons learned

  1. Laboratory workflows need special attention: laboratory data needs quality rules designed specifically for it.
  2. Working with laboratory teams when redesigning digital forms made sure the forms matched how laboratories really work.

Next: Resources and sources →

Sources

Explore more IRCE research